Summary
Concert Pharmaceuticals
Description
Alopecia Areata Research is a company dedicated to finding new approaches to treat alopecia areata, an unpredictable autoimmune disease. They provide resources and publications for individuals with alopecia areata.
Strengths
- There are no known strengths for Concert Pharmaceuticals
Weaknesses
- Concert Pharmaceuticals has a very small market share in their industry
- Revenue generated per employee is less than the industry average
Annual Revenue
Concert Pharmaceuticals's annual revenue
$5263000
Based on Kona Equity data
-
Revenue per employee
$478455
Employee Count
11 employees
G Score - 0
The G Score is an eight-point scale where firms are given a score of 1 for each of the criteria that they pass. The G score compares a company against the industry median to find those that are healthy and growing.
Location
None None None
Unlock unlimited leads
Similar Companies
Tanawisa
tanawisa.com- Founded in 1990
- Location: Chatsworth, CA
- Annual Revenue: $1.6M
- Employees: 12
- Tanawisa is a company that produces a helminthic supplement for autoimmune diseases, using porcine whipworm eggs.
ZaBeCor Pharmaceuticals
zabecor.com- Location: Bala Cynwyd, PA
- Annual Revenue: $2.7M
- Employees: 11
- ZaBeCor Pharmaceuticals is a leading pharmaceutical manufacturing company that specializes in the production of high-quality medications and healthcare products. With a strong commitment to innovation and research, ZaBeCor Pharmaceuticals develops and ...
Novoclinica
novoclinica.com- Founded in 2006
- Location: San Francisco, CA
- Annual Revenue: $4.2M
- Employees: 21
- Novoclinica, Inc. is a clinical research organization driven by vision For Better Medicine. We provide solutions for phase I-IV clinical trials in Russian and CIS markets.
Syndexa Pharmaceuticals
syndexa.com- Founded in 2005
- Location: Watertown, MA
- Annual Revenue: $5.4M
- Employees: 27
- Syndexa is dedicated to the discovery and development of a new generation of drugs targeting novel biological mechanisms for the treatment and prevention of metabolic diseases including obesity, type 2 diabetes, and cardiovascular disease.
Key Information
- Name: Concert Pharmaceuticals
- Category: Biotechnology
- SIC: 28; 283
- NAICS: 32; 325
See similar companies
-
By Category Biotechnology Small Biotechnology Mid-size Biotechnology
-
Firmographic data SIC: 28 SIC: 283 NAICS: 32 NAICS: 325 #Manufacturing General #Manufacturing
Frequently Asked Questions
Concert Pharmaceuticals's official website is alopeciaareataresearch.com
Concert Pharmaceuticals's annual revenue is $5.3 M.
Concert Pharmaceuticals's SIC: 28; 283
Concert Pharmaceuticals's NAICS: 32; 325.
Concert Pharmaceuticals has 11 employees
Concert Pharmaceuticals is in the industry of Biotechnology.
